ArticleOncotarget2017

Bleeding risk with dabigatran, rivaroxaban, warfarin, and antiplatelet agent in Asians with non-valvular atrial fibrillation.

Yi-Hsin Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.